abstract |
The present invention relates to certain novel pyrazine derivatives (as shown in Structural Formula I) which are useful as SHP2 inhibitors, as well as their synthesis and their use for the treatment of SHP2-mediated disorders. More particularly, the present invention relates to fused heterocyclic derivatives useful as SHP2 inhibitors, methods of preparing such compounds, and methods of treating SHP2-mediated diseases. |